Examkin

Soru

Zorluk: ZorDiagnostic and Screening Test Performance

A regional health department is optimizing a screening program for chronic kidney disease (CKD) using a novel urinary biomarker. The chief epidemiologist models several scenarios involving adjustments to the diagnostic positivity criteria and application across different demographic risk groups. Match each epidemiological or clinical scenario with its expected impact on the screening test's statistical performance parameters.

  • Decreasing the biomarker concentration cutoff threshold required to define a positive test resultIncreases the false-positive rate and decreases the positive predictive value
  • Increasing the biomarker concentration cutoff threshold required to define a positive test resultIncreases the false-negative rate and decreases the negative predictive value
  • Deploying the test in a specialized nephrology referral clinic rather than a general primary care settingIncreases the positive predictive value without altering the inherent sensitivity or specificity
  • Deploying the test for routine screening in a young, asymptomatic community cohortIncreases the negative predictive value without altering the inherent sensitivity or specificity
  • Applying the test in a population with a higher disease incidence but an identical overall point prevalenceResults in no change to the predictive values, sensitivity, or specificity

Cevap

The scenarios match based on the fundamental principles of diagnostic thresholds and disease prevalence: lowering cutoffs increases false positives; raising cutoffs increases false negatives; higher prevalence increases PPV; lower prevalence increases NPV; and isolated incidence changes without prevalence shifts have no effect.
Each scenario predictably alters test performance: threshold shifts dictate the trade-off between sensitivity/false-positives and specificity/false-negatives, while population prevalence shifts directly dictate predictive values without altering intrinsic test accuracy.

Adım Adım Çözüm

1
Analyze the impact of decreasing the diagnostic cutoff threshold.
Sensitivity increases and the false-positive rate increases, which mathematically causes the positive predictive value (PPV) to decrease.
A lower threshold captures more true cases but also incorrectly captures a larger proportion of healthy individuals.
2
Analyze the impact of increasing the diagnostic cutoff threshold.
Specificity increases and the false-negative rate increases, which mathematically causes the negative predictive value (NPV) to decrease.
A higher threshold correctly excludes more healthy individuals but incorrectly misses more true cases.
3
Analyze the impact of changing the tested population's disease prevalence.
Higher prevalence (referral clinic) increases PPV. Lower prevalence (asymptomatic cohort) increases NPV.
Prevalence dictates the pre-test probability of disease. It directly drives predictive values without altering the intrinsic sensitivity or specificity of the test.
4
Analyze the impact of isolated incidence changes with stable prevalence.
No change to any predictive values, sensitivity, or specificity.
Predictive values are determined by point prevalence, not the incidence rate. If point prevalence remains identical, predictive values are completely unaffected.

Anahtar Kavram

Diagnostic Test Characteristics: Threshold Adjustments and Population Prevalence Shifts
Bu soruyu puanla

Konular

Diagnostic and Screening Test Performance

Bu konudan daha fazla soru